Cardiovascular diseases and future risk of hip fracture in women

[1] Center JR(1999)Mortality after all major types of osteoporotic fracture in and women: an observational study Lancet 353 878-882

[2] Nguyen TV(2004)Mortality after osteoporotic fractures Osteoporosis Int 15 38-42

[3] Schneider D(2005)Survival after hip fracture Osteoporosis Int 16 1583-1590

[4] Sambrook PN(2004)Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels Osteoporosis Int 15 389-395

[5] Eisman JA(2001)Bone loss and the progression of abdominal aortic calcification of 25-year period: The Framingham Heart Study Calcif Tissue Int 68 271-276

[6] Johnell O(1999)The association between low bone mass at the menopause and cardiovascular mortality Am J Med 106 273-278

[7] Kanis JA(2005)Usefulness of bone mineral density to predict significant coronary artery disease Am J Cardiol 96 1059-1063

[8] Oden A(2004)Regulation of vascular calcification by osteoclast regulatory factors RANK-L and osteoprotegerin Circ Res 95 1046-1057

[9] Sernbo I(2004)Critical roles of c-Jun signaling in regulation of NFAT family and RANK-L regulated osteoclast differentiation J Clin Inv 114 475-484

[10] Redlund-Johnell I(1992)Modulation of osteoclast differentiation Endocr Rev 13 66-80

[1] Center JR(1999)Mortality after all major types of osteoporotic fracture in and women: an observational study Lancet 353 878-882

[2] Nguyen TV(2004)Mortality after osteoporotic fractures Osteoporosis Int 15 38-42

[3] Schneider D(2005)Survival after hip fracture Osteoporosis Int 16 1583-1590

[4] Sambrook PN(2004)Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels Osteoporosis Int 15 389-395

[5] Eisman JA(2001)Bone loss and the progression of abdominal aortic calcification of 25-year period: The Framingham Heart Study Calcif Tissue Int 68 271-276

[6] Johnell O(1999)The association between low bone mass at the menopause and cardiovascular mortality Am J Med 106 273-278

[7] Kanis JA(2005)Usefulness of bone mineral density to predict significant coronary artery disease Am J Cardiol 96 1059-1063

[8] Oden A(2004)Regulation of vascular calcification by osteoclast regulatory factors RANK-L and osteoprotegerin Circ Res 95 1046-1057

[9] Sernbo I(2004)Critical roles of c-Jun signaling in regulation of NFAT family and RANK-L regulated osteoclast differentiation J Clin Inv 114 475-484

[10] Redlund-Johnell I(1992)Modulation of osteoclast differentiation Endocr Rev 13 66-80